| Prev Close: | 10.97 |
|---|---|
| Open: | N/A |
| Bid: | 7.53 x 100 |
| Ask: | N/A |
| 1y Target Est: | N/A |
| Beta: | 2.06 |
| Next Earnings Date: | 29-Jul-13 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 2.25 - 12.50 |
| Volume: | 0 |
| Avg Vol (3m): | 524,317 |
| Market Cap: | 338.19M |
| P/E (ttm): | 51.02 |
| EPS (ttm): | 0.22 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Albany Molecular Research Management Presents at UBS Global Healthcare (Transcript)at Seeking Alpha(Wed, May 22)
- ALBANY MOLECULAR RESEARCH INC FinancialsEDGAR Online Financials(Fri, May 17)
- The Son of the Father of Indexing is Beating the Index Again This Yearat Barrons.com(Wed, May 15)
- AMRI CFO to Present at the UBS Global Healthcare ConferencePR Newswire(Wed, May 15)
- ALBANY MOLECULAR RESEARCH INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, May 9)
- ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online(Wed, May 8)
- Albany Molecular Research's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, May 7)
- AMRI Announces First Quarter 2013 Results and Raises EPS Guidance for the YearPR Newswire(Tue, May 7)
- Q1 2013 Albany Molecular Research Earnings Release - Before Market OpenCCBN(Tue, May 7)
- Finding Innovative Drugs that are Genuinely Differentiated and Not an Incremental Improvement is the Key to Biotech Success, According to Expert Analyst Boris PeakerWall Street Transcript(Wed, May 1)
- AMRI to Announce First Quarter ResultsPR Newswire(Wed, Apr 24)
- AMRI and Ono Broaden SMARTSOURCING™ CollaborationPR Newswire(Tue, Apr 23)
- AMRI CEO to Present at the 12th Annual Needham Healthcare ConferencePR Newswire(Tue, Apr 23)
- Biotech Stocks Get A Turbo Boost From Vertexat Seeking Alpha(Sat, Apr 20)
- The “Healthy” Play In Contract Research Organizationsat Investopedia(Wed, Apr 17)
Press Releases
- AMRI CFO to Present at the UBS Global Healthcare ConferencePR Newswire(Wed, May 15)
- AMRI Announces First Quarter 2013 Results and Raises EPS Guidance for the YearPR Newswire(Tue, May 7)
- AMRI to Announce First Quarter ResultsPR Newswire(Wed, Apr 24)
Reports
- AMRI: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 22)
- ValuEngine Industry Report for Medical ServicesValuEngine, Inc.(May 22)
- ALBANY MOLECULAR RESEARCH (AMRI) - REPORT FOR ACTIVE TRADERSPechala's Reports(May 20)